EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge

N/AUnknownNCT02977650

Hokkaido Pancreatobiliary Endoscopic Intervention Study Group150 enrolled

Overview

To evaluate the feasibility of EUS-FNA for patients taking anticoagulants without heparin bridge.

Study Type

OBSERVATIONAL

Enrollment

150

Conditions

Endoscopic Ultrasonography-guided Fine Needle Aspiration

Interventions

Endoscopic ultrasonography-guided fine needle aspirationPROCEDURE

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Taking anticoagulants * Written informed consent Exclusion Criteria: * Platelets count less than 50000/μl * PT-INR more than 2.6 * ASA more than 3 * Severe bleeding tendency

Locations (1)

Hokkaido University Hospital

Sapporo, Japan

RECRUITING

Outcomes

Primary Outcomes

The rate of bleeding adverse events

Time frame: Within 2 weeks

Secondary Outcomes

The rate of thromboembolic events

Time frame: Within 2 weeks

The rate of other adverse events

Time frame: Within 2 weeks

Central Contacts

Kazumichi Kawakubo, Ph.D.

CONTACT

117161161 kkawakubo-gi@umin.ac.jp

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.